Zobrazeno 1 - 10
of 98
pro vyhledávání: '"B.G. Mobbs"'
Autor:
David R. McCready, Kathleen I. Pritchard, Judy-Anne W. Chapman, David Murray, Wedad Hanna, Carol Sawka, Harriette J. Kahn, H.L.A. Lickley, B.G. Mobbs, Maureen E. Trudeau, E.B. Fish
Publikováno v:
European Journal of Cancer. 32:1949-1956
Recently, there has been a proliferation of new biomarkers, some of which may lead to an improved prognostic index or may influence treatment selection. However, there are methodological and statistical issues that require attention in assessing the
Autor:
Carol Sawka, Harriette J. Kahn, Wedad Hanna, David R. McCready, Judy-Anne W. Chapman, E.B. Fish, Kathleen I. Pritchard, B.G. Mobbs, H.L.A. Lickley, Maureen E. Trudeau
Publikováno v:
The Journal of Steroid Biochemistry and Molecular Biology. 57:323-328
Oestrogen and progesterone receptor (ER and PgR) assay values are frequently used in medical decision-making for breast cancer patients. We have proposed statistical standardization of receptor assay values to improve inter-laboratory comparability,
Autor:
Gladys A. Oldfield, G.Geneitha Allen, Maureen E. Trudeau, Carol Sawka, Harriette J. Kahn, Wedad Hanna, H. Lavina A. Lickley, Judy-Anne W. Chapman, Kathleen I. Pritchard, B.G. Mobbs, David R. McCready
Publikováno v:
Journal of Clinical Epidemiology. 48:779-786
The cohort study design has been used successfully in clinical cancer research. Cohorts, however, are valuable only if they produce results which are valid and generalizable. Some hospital-based inception cohorts satisfy both these requirements and m
Changes in tumor characteristics during progression of the R3327 HI experimental prostatic carcinoma
Autor:
B.G. Mobbs, I.E. Johnson
Publikováno v:
The Prostate. 16:127-136
The R3327 HI experimental prostatic carcinoma was serially transplanted through six generations of castrated host rats to examine changes in the capacity to synthesize progesterone receptor (PgR) in response to diethylstilbestrol (DES) stimulation du
Publikováno v:
The Prostate. 16:235-244
Estrogen receptor (ER) and progesterone receptor (PgR) were quantitated in benign and malignant human prostatic tissue by using radioligand binding assays (RBA) and enzyme-immunoassays (EIA). Using a hydroxylapatite exchange method for ER, little or
Autor:
Kathleen I. Pritchard, David R. McCready, H. Lavina A. Lickley, Wedad Hanna, Harriette J. Kahn, Maureen E. Trudeau, Alexander Marks, Judy-Anne W. Chapman, David Murray, Carol Sawka, B.G. Mobbs
Publikováno v:
The breast journal. 12(4)
The biological significance of occult metastases in axillary lymph nodes of breast cancer patients is controversial. The purpose of the study was to determine the prognostic significance of occult micrometastases using the current American Joint Comm
Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis
Autor:
Kathleen I. Pritchard, David Murray, Maureen E. Trudeau, Carol Sawka, Wedad Hanna, H. Lavina A. Lickley, Harriette J. Kahn, B.G. Mobbs, Judith-Anne W. Chapman, David R. McCready
Publikováno v:
The breast journal. 12(1)
Clinical decisions to administer adjuvant systemic therapy to women with early breast cancer require knowledge about baseline prognosis, which is only assessable in the absence of such adjuvant treatment, which most patients currently do receive. The
Autor:
Maureen E. Trudeau, Harriette J. Kahn, Judy-Anne W. Chapman, Wedad Hanna, B.G. Mobbs, H. Lavina A. Lickley, Irene L. Andrulis, David Murray, Carol Sawka, Kathleen I. Pritchard, David R. McCready
Publikováno v:
Breast cancer research and treatment. 89(1)
We undertook a natural history investigation of a broad selection of prognostic factors in a cohort of women with node-negative breast cancer.The cohort consisted of 415 consecutive histologic node-negative (T1-3, M0) patients, operated on for primar
Autor:
Donald J.A. Sutherland, Judy-Anne W. Chapman, Eugene R. Tustanoff, Maureen E. Trudeau, Eamonn D. Ryan, H. Lavina A. Lickley, Wedad Hanna, Teik Chye Ooi, Carol Sawka, David R. McCready, Kathleen I. Pritchard, B.G. Mobbs
Publikováno v:
The Journal of steroid biochemistry and molecular biology. 45(5)
Tumour estrogen receptor (ER) status may determine the medical treatment of a patient with breast cancer; yet inter-laboratory results can vary markedly, particularly when absolute cut-offs in fmol/mg cytosol protein are used. The use of standardized
Autor:
Judy-Anne W. Chapman, Donald J.A. Sutherland, Eamonn D. Ryan, Eugene R. Tustanoff, B.G. Mobbs, P.V.Narasimha Murthy, Teik Chye Ooi
Publikováno v:
European journal of cancer (Oxford, England : 1990). (9)
Breast carcinoma oestrogen receptor (ER) and progesterone receptor (PgR) values obtained by radioligand binding assays have commonly been observed to have approximate log-normal distributions. We examined the distribution of log-transformed receptor